Ozempic manufacturer Novo Nordisk said patient safety is a priority and “the benefit-risk profile of semaglutide remains ...

The Polish initiative establishes a proactive strategy for securing access to essential medicines and maintaining ...

The European Union’s drug regulator said it would review two studies that link Novo Nordisk’s blockbuster diabetes drug ...

Following an appeal by the Danish Medicines Agency, the European Union’s drug regulator will review two new studies that have ...

The European Union's drug regulator said it would assess two new Danish studies that link Novo Nordisk's popular diabetes ...

In one of the final steps before a marketing authorization decision by the European Medicines Agency, it recommended ...

How are emerging plasma biomarkers related to the diagnostic tests currently used in clinical routines? And does the earlier ...

The European MCL Network Phase 3 TRIANGLE study, evaluated ibrutinib in combination with induction immunochemotherapy, both with and without an autologous stem cell transplant, followed by 24 months f ...

BENGALURU: Biocon Biologics, a biosimilars company and subsidiary of Biocon, has announced that the European Medicines Agency ...

Several recent studies have found a possible connection between semaglutide use and a rare condition that causes sudden ...

The Danish Medicines Agency said it would ask European authorities to review two new studies that point to a link between ...